glp-1 r retatrutide vs Semaglutide and Tirzepatide: GLP-3 Facts explained Beyond GLP-1: Retatrutide's triple-agonist mechanism

Implant-derived magnesium induces local neuronal production of CGRP to improve bone-fracture healing in rats

They welcome questions about their manufacturing and quality control processes

Losing 5% to 10% of body weight through diet and exercise reduces the risk of cardiovascular disease, but diet and exercise alone are not always guaranteed to address the issue

At 48 weeks, weight loss was dose-dependent: the 12 mg group achieved approximately 24.2% mean weight loss, which was meaningfully higher than the approximately 15% reported for semaglutide 2.4 mg in the STEP 1 trial and approximately 20-22% for tirzepatide in the SURMOUNT trials